Johnson & Johnson Innovation Announces Winner of the European Innovation QuickFire Challenge: AlphaBiomics

November 5, 2018 -
1 month ago
Other news

Copenhagen, Denmark, November 5, 2018 — Johnson & Johnson Innovation, JLABS (JLABS) announced today that London-based AlphaBiomics, a precision medicine company, has been selected as the winner of the European Innovation QuickFire Challenge. The Challenge was designed to identify innovators with the best idea, technology, or solution that has the potential to improve human healthcare and impact the European life sciences ecosystem.

AlphaBiomics develops microbiome-based precision medicine solutions to predict drug response and improve drug therapy. By deciphering how gut microbiome influences individual responses to medicines, AlphaBiomics predicts how well individuals will respond to particular therapies and designs companion therapeutics to boost patient response to their medicines. AlphaBiomics will employ their platform to deliver safer and more efficacious immunotherapy in autoimmune diseases.

As the winner of the European Innovation QuickFire Challenge, AlphaBiomics will receive €100,000 in grant funding to further advance its solutions in human healthcare as well as a voucher for one year of residency at an available JLABS location. A JLABS residency includes a laboratory bench, workstation and access to the global JLABS community.

The QuickFire Challenges are managed by JLABS, a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world.

For more information about the QuickFire Challenge, please visit: https://jlabs.jnjinnovation.com/quickfire-challenges.

 

About Johnson & Johnson Innovation 

Johnson & Johnson Innovation Limited focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com or follow @JNJinnovation.

 

About Johnson & Johnson Innovation, JLABS

Johnson & Johnson InnovationJLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS

 


Related content